Mitochondria transplant for Parkinson's disease
Part of Brain & nervous system clinical trials.
This trial tests whether transplanting a person's own mitochondria (the energy-producing parts of cells) into the brain can safely improve Parkinson's disease symptoms. It is for people who have had Parkinson's for at least 5 years and are still responding to their usual Parkinson's medication.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 45 and 70 years old.
- You have had a Parkinson's disease diagnosis for at least 5 years.
- Your Parkinson's symptoms improve by at least 33% when you take your Parkinson's medication.
- You are in stage 3 or 4 on the Hoehn and Yahr scale (meaning your balance is affected but you can still walk and stand).
- Your Parkinson's medications have been stable for at least 2 months.
- You are generally healthy enough to undergo brain surgery and anesthesia, and you do not have other major health conditions.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether transplanting specially grown cells (DopaCell) into the brain can safely help people with moderate Parkinson's disease whose symptoms aren't well controlled by medication. The cells are intended to produce dopamine, the chemical that Parkinson's affects.
This trial tests whether transplanting special dopamine-producing cells made from a patient's own skin cells can help treat Parkinson's disease. It is for people who have had Parkinson's for at least 5 years and still respond well to medication.
This trial tests whether implanting your own stem cells (made into dopamine-producing brain cells) can improve Parkinson's motor symptoms. You would need to be a candidate for brain surgery and have a stable medication routine.
This trial tests a new type of cell transplant for Parkinson's disease. The cells are made from stem cells and are meant to replace damaged brain cells that produce dopamine, which may improve your motor symptoms.
This trial studies whether a special type of stem cell treatment can help people with Parkinson's disease or certain atypical parkinsonism conditions. The treatment involves harvesting your own bone marrow stem cells and optimizing them in the lab before giving them back to you. It aims to see if this can slow down the disease or improve symptoms.
This trial tests a new cell treatment for Parkinson's disease. It involves injecting special cells into the brain to see if they can safely replace damaged cells and improve symptoms. It might help people who have had Parkinson's for several years and still respond well to medication.
Hear when a new Idiopathic Parkinson's Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.